Location History:
- North Bay Vilage, FL (US) (2012)
- Miami, CA (US) (2014)
- Miami, FL (US) (2002 - 2017)
- Fort Lauderdale, FL (US) (2016 - 2017)
- North Bay Village, FL (US) (2007 - 2024)
Company Filing History:
Years Active: 2002-2024
Title: **Deborah C. Mash: A Pioneer in Pharmaceutical Innovations**
Introduction
Deborah C. Mash is a distinguished inventor based in Miami, Florida, with an impressive portfolio of 21 patents to her name. Her innovative contributions primarily focus on pharmaceutical compounds and their applications, especially in the realms of pain management, addiction treatment, and stress relief.
Latest Patents
Among her latest patents, Deborah has developed formulations that include substituted noribogaine and N-substituted noribogaine prodrugs. The invention of substituted noribogaine revolves around derivatives, compositions, and methods of use pertaining to noribogaine, providing a significant advancement in therapeutic options. Furthermore, her work on N-substituted noribogaine prodrugs addresses the need for effective pharmaceutical compositions that can enhance treatment outcomes for various conditions related to pain and addiction.
Career Highlights
Deborah's career is marked by her commitment to pharmaceutical innovation. She has made substantial contributions through her patents that highlight her expertise in synthesizing compounds with the potential to improve patient care. Her work has laid the foundation for new treatment protocols in both clinical and research settings.
Collaborations
During her career, Deborah has had the pleasure of collaborating with notable professionals in the field, including Robert M. Moriarty and Richard D. Gless. These partnerships have undoubtedly enriched her research efforts and contributed to the advancement of pharmaceutical sciences.
Conclusion
In summary, Deborah C. Mash stands out as a significant figure in the arena of pharmaceutical innovations. Her 21 patents underscore her dedication to tackling pressing issues in pain management and addiction treatment. As she continues her work in the field, her contributions are expected to have a lasting impact on both scientific research and public health.